SIS Stock Analysis: Savaria | TO
Specialty Industrial Machinery | TO, Canada | Market Cap: 2.182m CAD | 12M Return: 32.5% | CA8051121090 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.41M
EPS Trend: 99.0%
Qual. Beats: 0
Rev. Trend: 98.2%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 11.8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Savaria Corporation (TSX: SIS), headquartered in Laval, Canada, designs, manufactures, distributes, and installs accessibility and patient-care equipment across Canada, the United States, Europe, and other markets. Its products include elevators, stairlifts, wheelchair-accessible vehicles, patient lifts, medical beds, and pressure-management products for homes, businesses, and healthcare settings.
The company sells through dealers and its own stores, as well as directly to end users. Its business serves people with mobility needs and the facilities that care for them, across the industrial machinery and supplies sector.
- Aging populations and accessibility upgrades support elevator and stairlift demand
- Hospital staffing pressures drive patient-handling equipment adoption
- Acquisition integration, product mix and costs shape margins and cash flow
| Net Income: 87.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -0.25 > 1.0 |
| NWC/Revenue: 14.56% < 20% (prev 15.84%; Δ -1.28% < -1%) |
| CFO/TA 0.12 > 3% & CFO 141.2m > Net Income 87.9m |
| Net Debt (223.1m) to EBITDA (188.4m): 1.18 < 3 |
| Current Ratio: 1.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (73.5m) vs 12m ago 2.95% < -2% |
| Gross Margin: 39.15% > 18% (prev 37.91%; Δ 1.24% > 0.5%) |
| Asset Turnover: 83.56% > 50% (prev 78.81%; Δ 4.75% > 0%) |
| Interest Coverage Ratio: 11.84 > 6 (EBIT TTM 131.9m / Interest Expense TTM 11.1m) |
| A: 0.12 (Total Current Assets 329.6m - Total Current Liabilities 191.5m) / Total Assets 1.15b |
| B: 0.06 (Retained Earnings 65.3m / Total Assets 1.15b) |
| C: 0.12 (EBIT TTM 131.9m / Avg Total Assets 1.13b) |
| D: 1.50 (Book Value of Equity 688.3m / Total Liabilities 458.8m) |
| Altman-Z'' = 3.33 = A |
| DSRI: 1.04 (Receivables 125.3m/112.5m, Revenue 947.9m/884.0m) |
| GMI: 0.97 (GM 37.91% / 39.15%) |
| AQI: 0.97 (AQ_t 0.60 / AQ_t-1 0.62) |
| SGI: 1.07 (Revenue 947.9m / 884.0m) |
| TATA: -0.05 (NI 87.9m - CFO 141.2m) / TA 1.15b) |
| Beneish M = -2.99 (Cap -4..+1) = A |
As of November 02, 2026, the stock is trading at CAD 28.35 with a total of 225,052 shares traded. Over the past week, the price has changed by -6.13%, over one month by +0.80%, over three months by -3.07% and over the past year by +32.51%.
Current recommended Stop Loss: 27.20 (which is 4.1% or 1.8 ATR below the current price).
Savaria has no consensus analysts rating.
P/E Trailing = 25.0
P/E Forward = 16.3934
P/S = 2.3017
P/B = 2.4244
Revenue TTM = 947.9m CAD
EBIT TTM = 131.9m CAD
EBITDA TTM = 188.4m CAD
Long Term Debt = 147.5m CAD (from longTermDebt, last quarter)
Short Term Debt = 13.9m CAD (from shortTermDebt, last quarter)
Debt = 256.5m CAD (from shortLongTermDebtTotal, last quarter) + Leases 53.9m
Net Debt = 223.1m CAD (calculated: Debt 256.5m - CCE 33.5m)
Enterprise Value = 2.40b CAD (2.18b + Debt 256.5m - CCE 33.5m)
Interest Coverage Ratio = 11.84 (Ebit TTM 131.9m / Interest Expense TTM 11.1m)
EV/FCF = 20.97x (Enterprise Value 2.40b / FCF TTM 114.7m)
FCF Yield = 4.77% (FCF TTM 114.7m / Enterprise Value 2.40b)
FCF Margin = 12.10% (FCF TTM 114.7m / Revenue TTM 947.9m)
Net Margin = 9.27% (Net Income TTM 87.9m / Revenue TTM 947.9m)
Gross Margin = 39.15% ((Revenue TTM 947.9m - Cost of Revenue TTM 576.8m) / Revenue TTM)
Gross Margin QoQ = 39.58% (prev 38.95%)
Tobins Q-Ratio = 2.10 (Enterprise Value 2.40b / Total Assets 1.15b)
Interest Expense / Debt = 4.34% (Interest Expense 11.1m / Debt 256.5m)
Taxrate = 23.29% (26.7m / 114.5m)
NOPAT = 101.2m (EBIT 131.9m * (1 - 23.29%))
Current Ratio = 1.72 (Total Current Assets 329.6m / Total Current Liabilities 191.5m)
Debt / Equity = 0.37 (Debt 256.5m / totalStockholderEquity, last quarter 688.3m)
Debt / EBITDA = 1.18 (Net Debt 223.1m / EBITDA 188.4m)
Debt / FCF = 1.95 (Net Debt 223.1m / FCF TTM 114.7m)
Total Stockholder Equity = 655.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.75% (Net Income 87.9m / Total Assets 1.15b)
RoE = 13.41% (Net Income TTM 87.9m / Total Stockholder Equity 655.2m)
RoCE = 16.43% (EBIT 131.9m / Capital Employed (Equity 655.2m + L.T.Debt 147.5m))
RoIC = 10.81% (NOPAT 101.2m / Invested Capital 936.1m)
WACC = 7.20% (E(2.18b)/V(2.44b) * Re(7.66%) + D(256.5m)/V(2.44b) * Rd(4.34%) * (1-Tc(0.23)))
Discount Rate = 7.66% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 79.95 | Cagr: 1.42%
[DCF] Terminal Value 75.41% ; FCFF base≈114.8m ; Y1≈115.1m ; Y5≈121.5m
[DCF] Fair Price = 23.11 (EV 1.89b - Net Debt 223.1m = Equity 1.67b / Shares 72.1m; r=8.35% [WACC [floored]]; 5y FCF grow -0.20% → 2.50% )
EPS Correlation: 99.04 | EPS CAGR: 35.96% | SUE: 0.43 | # QB: 0
Revenue Correlation: 98.21 | Revenue CAGR: 4.73% | SUE: 0.67 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.35 | Chg30d=+0.00% | Revisions=-25% | Analysts=6
EPS current Year (2026-12-31): EPS=1.38 | Chg30d=-0.18% | Revisions=-25% | GrowthEPS=+14.3% | GrowthRev=+7.7%
EPS next Year (2027-12-31): EPS=1.56 | Chg30d=+0.09% | Revisions=+25% | GrowthEPS=+12.9% | GrowthRev=+6.5%
[Analyst] Revisions Ratio: -17% (up=1, down=2)